Cargando…

Understanding hesitancy with revealed preferences across COVID-19 vaccine types

Many countries have secured larger quantities of COVID-19 vaccines than their population is willing to take. The abundance and the large variety of vaccines created not only an unprecedented intensity of vaccine related public discourse, but also a historical moment to understand vaccine hesitancy b...

Descripción completa

Detalles Bibliográficos
Autores principales: Kutasi, Kristóf, Koltai, Júlia, Szabó-Morvai, Ágnes, Röst, Gergely, Karsai, Márton, Biró, Péter, Lengyel, Balázs
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345393/
https://www.ncbi.nlm.nih.gov/pubmed/35918372
http://dx.doi.org/10.1038/s41598-022-15633-5
_version_ 1784761422333345792
author Kutasi, Kristóf
Koltai, Júlia
Szabó-Morvai, Ágnes
Röst, Gergely
Karsai, Márton
Biró, Péter
Lengyel, Balázs
author_facet Kutasi, Kristóf
Koltai, Júlia
Szabó-Morvai, Ágnes
Röst, Gergely
Karsai, Márton
Biró, Péter
Lengyel, Balázs
author_sort Kutasi, Kristóf
collection PubMed
description Many countries have secured larger quantities of COVID-19 vaccines than their population is willing to take. The abundance and the large variety of vaccines created not only an unprecedented intensity of vaccine related public discourse, but also a historical moment to understand vaccine hesitancy better. Yet, the heterogeneity of hesitancy by vaccine types has been neglected in the existing literature so far. We address this problem by analysing the acceptance and the assessment of five vaccine types. We use information collected with a nationally representative survey at the end of the third wave of the COVID-19 pandemic in Hungary. During the vaccination campaign, individuals could reject the assigned vaccine to wait for a more preferred alternative that enables us to quantify revealed preferences across vaccine types. We find that hesitancy is heterogenous by vaccine types and is driven by individuals’ trusted source of information. Believers of conspiracy theories are more likely to evaluate the mRNA vaccines (Pfizer and Moderna) unacceptable. Those who follow the advice of politicians are more likely to evaluate vector-based (AstraZeneca and Sputnik) or whole-virus vaccines (Sinopharm) acceptable. We argue that the greater selection of available vaccine types and the free choice of the individual are desirable conditions to increase the vaccination rate in societies.
format Online
Article
Text
id pubmed-9345393
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-93453932022-08-03 Understanding hesitancy with revealed preferences across COVID-19 vaccine types Kutasi, Kristóf Koltai, Júlia Szabó-Morvai, Ágnes Röst, Gergely Karsai, Márton Biró, Péter Lengyel, Balázs Sci Rep Article Many countries have secured larger quantities of COVID-19 vaccines than their population is willing to take. The abundance and the large variety of vaccines created not only an unprecedented intensity of vaccine related public discourse, but also a historical moment to understand vaccine hesitancy better. Yet, the heterogeneity of hesitancy by vaccine types has been neglected in the existing literature so far. We address this problem by analysing the acceptance and the assessment of five vaccine types. We use information collected with a nationally representative survey at the end of the third wave of the COVID-19 pandemic in Hungary. During the vaccination campaign, individuals could reject the assigned vaccine to wait for a more preferred alternative that enables us to quantify revealed preferences across vaccine types. We find that hesitancy is heterogenous by vaccine types and is driven by individuals’ trusted source of information. Believers of conspiracy theories are more likely to evaluate the mRNA vaccines (Pfizer and Moderna) unacceptable. Those who follow the advice of politicians are more likely to evaluate vector-based (AstraZeneca and Sputnik) or whole-virus vaccines (Sinopharm) acceptable. We argue that the greater selection of available vaccine types and the free choice of the individual are desirable conditions to increase the vaccination rate in societies. Nature Publishing Group UK 2022-08-02 /pmc/articles/PMC9345393/ /pubmed/35918372 http://dx.doi.org/10.1038/s41598-022-15633-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Kutasi, Kristóf
Koltai, Júlia
Szabó-Morvai, Ágnes
Röst, Gergely
Karsai, Márton
Biró, Péter
Lengyel, Balázs
Understanding hesitancy with revealed preferences across COVID-19 vaccine types
title Understanding hesitancy with revealed preferences across COVID-19 vaccine types
title_full Understanding hesitancy with revealed preferences across COVID-19 vaccine types
title_fullStr Understanding hesitancy with revealed preferences across COVID-19 vaccine types
title_full_unstemmed Understanding hesitancy with revealed preferences across COVID-19 vaccine types
title_short Understanding hesitancy with revealed preferences across COVID-19 vaccine types
title_sort understanding hesitancy with revealed preferences across covid-19 vaccine types
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345393/
https://www.ncbi.nlm.nih.gov/pubmed/35918372
http://dx.doi.org/10.1038/s41598-022-15633-5
work_keys_str_mv AT kutasikristof understandinghesitancywithrevealedpreferencesacrosscovid19vaccinetypes
AT koltaijulia understandinghesitancywithrevealedpreferencesacrosscovid19vaccinetypes
AT szabomorvaiagnes understandinghesitancywithrevealedpreferencesacrosscovid19vaccinetypes
AT rostgergely understandinghesitancywithrevealedpreferencesacrosscovid19vaccinetypes
AT karsaimarton understandinghesitancywithrevealedpreferencesacrosscovid19vaccinetypes
AT biropeter understandinghesitancywithrevealedpreferencesacrosscovid19vaccinetypes
AT lengyelbalazs understandinghesitancywithrevealedpreferencesacrosscovid19vaccinetypes